The increasing resistance to antimicrobial drugs has instigated the crucial need for the discovery of novel compounds with different modes of action that could target both sensitive and resistant strains. For this purpose, we developed some new chalcone analogs. Herein, a novel series of hybrid biphenyl chalcones (17-24), which have organohalogens in their B ring, were synthesized and examined for their antimicrobial effect. The position of the substituent on ring B was changed to find the effect of the substitution on antimicrobial activity. Compounds 18, 19, and 24 showed better antibacterial and antifungal activity when compared other compounds. Also, molecular docking studies on ATP binding site of S. aureus DNA gyrase for antibacterial targets were performed to elucidate the mechanism of antibacterial activity of synthesized compounds. Three of the most active compounds could be considered as lead compounds for the development of more new potent agents.
Two different amino piperazine derivatives bearing various halogen groups were synthesized in high yields and explored in further transformations. Reacting these amino piperazines with various sulfonyl chlorides yielded eight different sulfonamides. Additionally, eight different urea derivatives have been prepared by treating these amino piperazines with isocyanates. Finally, we were able to take advantage of the aryl bromide functionality present in the parent amino piperazines by subjecting them to the Suzuki coupling with phenylboronic acid. Overall, we developed a strategy to diversify the amino piperazine core and obtained a small library of potentially bioactive piperazine derivatives.
1 November 2025 in Russian Journal of General Chemistry
Substituted tetrahydroquinoline (THQ) derivatives were systematically designed and synthesized via a three-component Povarov reaction, employing N-vinyl carbamate, organocatalyzed substituted anilines, and benzaldehyde derivatives. The resulting THQ derivatives demonstrated a diverse range of functional groups, which potentially broadens their applicability. These compounds were rigorously characterized using various spectroscopic techniques to verify their structures. Subsequent bioevaluation of the synthesized THQs revealed their inhibitory activity against acetylcholinesterase (AChE), highlighting their potential as therapeutic agents for neurodegenerative diseases. All synthesized THQs exhibited IC50 values ranging from 0.22 to 0.36 μM, which are lower than the IC50 value of the standard compound tacrine (0.77 μM). The Ki values for the THQs against AChE ranged from 0.370±0.330 to 1.30±0.715 μM. Additionally, molecular docking studies of the THQ-AChE complexes yielded binding scores between –10.8 and –12.4 kcal/mol. The structure-activity relationship (SAR) analysis underscores the significance of THQ structures in medicinal chemistry. These findings suggest that the structural insights gained from this study will be valuable for the future design and synthesis of potent AChE inhibitors.